Detection of F8 mutations in carriers and patients with severe hemophilia A. Identification of a novel mutation
{{output}}
The molecular diagnosis of haemophilia A (HA) patients has many benefits including diagnosis confirmation and inhibitor risk development prediction. In female carries of a mutation, the molecular diagnosis allows for genetic counseling and prenatal diagnosis, ... ...
